Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3M Buy
2,000,000
+25,000
+1% +$208K 0.82% 30
2025
Q4
$20.6M Buy
1,975,000
+350,000
+22% +$3.51M 1.39% 26
2025
Q3
$14.6M Buy
1,625,000
+425,000
+35% +$3.73M 0.96% 25
2025
Q2
$15.6M Buy
1,200,000
+600,000
+100% +$9.02M 1.15% 24
2025
Q1
$15.2M Buy
600,000
+100,000
+20% +$2.97M 1.18% 21
2024
Q4
$17.2M Buy
500,000
+25,000
+5% +$1.13M 1.14% 23
2024
Q3
$23.5M Buy
475,000
+125,000
+36% +$6.4M 1.81% 23
2024
Q2
$21.1M Sell
350,000
-25,000
-7% -$1.43M 1.29% 25
2024
Q1
$19.3M Sell
375,000
-50,000
-12% -$2.45M 1.43% 23
2023
Q4
$17.1M Buy
425,000
+175,000
+70% +$5.13M 1.71% 22
2023
Q3
$6.97M Buy
+250,000
New +$7.45M 0.83% 27

Other funds holding RXST

No Street GP LP's RXST Position: Q1 2026 in Review

No Street GP LP increased its RxSight (RXST) stake by 1.3% in Q1 2026, buying an estimated $208K and bringing the position to 2,000,000 shares worth $12.3M. The position accounts for 0.82% of the portfolio, ranked #30.

No Street GP LP first reported a position in RXST in Q3 2023 and has held it in 11 quarters since. The position peaked at $23.5M in Q3 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • No Street GP LP held 2,000,000 shares of RxSight worth $12.3M as of Q1 2026.
  • No Street GP LP bought 25,000 RxSight shares in Q1 2026, an estimated $208K.
  • RxSight made up 0.82% of No Street GP LP's portfolio in Q1 2026, its #30 holding.
  • No Street GP LP first reported a position in RxSight in Q3 2023 and has held it in 11 quarters since.
  • No Street GP LP's RxSight position peaked at $23.5M in Q3 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on No Street GP LP's 13F filing for Q1 2026, filed 15 May 2026.